🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Uwe Schoenbeck

Uwe Schoenbeck

Venture Partner·Canaan Partners

Bio

Professional summary

Uwe Schoenbeck is a Venture Partner at Canaan, where he helps drive new healthcare investments and company creation using scientific and pharmaceutical R&D experience. Before Canaan, he was Senior Vice President and Chief Scientific Officer, Emerging Science & Innovation, in Pfizer’s Worldwide Development & Medical division. Earlier roles included Vice President, Emerging R&D Innovation at Wyeth and Vice President, Cardiovascular Research at Boehringer Ingelheim.

Notable companies

Selected portfolio companies the partner has backed

Alterome Therapeutics

Background

Career, education, and skills

Career history

  • CanaanVenture Partner2024 – Present
  • PfizerSenior Vice President and Chief Scientific Officer, Emerging Science & Innovation
  • WyethVice President, Emerging R&D Innovation
  • Boehringer IngelheimVice President, Cardiovascular Research

Education

  • University of KielDegree
  • Brigham & Women’s Hospital / HarvardPostdoctoral training, Division of Cardiovascular Medicine

Other partners at Canaan Partners

12 more profiles

Brendan Dickinson

Brendan Dickinson

General Partner / East Coast

Canaan Partners

Canaan General Partner leading the firm’s fintech practice, with emphasis on fintech infrastructure, platforms, products, and insurance.

fintech infrastructureplatform companies
Brent Ahrens

Brent Ahrens

General Partner / West Coast

Canaan Partners

Canaan GP focused on biopharma and medtech investments.

BiopharmaHealthcareLife sciencesMedical devicesMedtech
Butch Yang

Butch Yang

Head of Venture Investments

Canaan Partners

Head of Venture Investments at Canaan.

Early-stage investingHealthcareTechnologyVenture capital
Colleen Cuffaro

Colleen Cuffaro

Partner

Canaan Partners

Canaan partner focused on early-stage biopharmaceutical companies.

BiopharmaDrug discoveryEarly-stage healthcareOncologyRNA therapeutics
Dennis Podlesak

Dennis Podlesak

Managing Partner, Canaan Partners’ Axcelius

Canaan Partners

Canaan Axcelius managing partner and biotech operator-investor.

BiotechCompany formationLife sciencesPharmaceuticalsTherapeutics
Ehud Levy

Ehud Levy

General Partner

Canaan Partners

Canaan Partners Israel GP who led Vertex's early investment in Waze.

Digital mediaEarly-stage technologyEnterprise softwareIsraeli startupsMobile
Eric Young

Eric Young

Partner and Co-Founder

Canaan Partners

Canaan co-founder who helped lead the firm for more than three decades.

Firm buildingInvestment leadershipTechnologyVenture capital
Felipe Ossio

Felipe Ossio

Vice President

Canaan Partners

Canaan VP investing in fintech and consumer technology.

Business operationsConsumer technologyEarly-stage startupsFintechTechnology
GK

Gregory Kopchinsky

General Partner

Canaan Partners

Longtime Canaan general partner with J.P. Morgan and Davis Polk financing experience.

Private equityPrivate financingsTechnology investingVenture capital
Hrach Simonian

Hrach Simonian

General Partner / West Coast

Canaan Partners

General Partner at Canaan focused on technology investments, with a marketplace-oriented lens across consumer and enterprise companies.

consumer techenterprise techmarketplaces
Ingrid Prueher

Ingrid Prueher

Fund Analyst

Canaan Partners

Formerly cited as a Canaan fund analyst with a finance and wellness entrepreneurship background.

FinanceFund analysisOperationsWellness entrepreneurship
John Balen

John Balen

Partner

Canaan Partners

Canaan technology partner investing across consumer and enterprise companies.

Consumer technologyEarly-stage technologyEnterprise technologyMarketplacesSaaS